Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia

Overview of attention for article published in Cell Reports, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 12 X users

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 196,668 followers.

RT @TheVFoundation: It’s time to “C” your research update! 2021 Early Career Investigator Dr. Luisa Cimmino, & team @SylvesterCancer, discu…

It’s time to “C” your research update! 2021 Early Career Investigator Dr. Luisa Cimmino, & team @SylvesterCancer, discuss the role vitamin C plays in therapeutic efficacy for FDA-approved acute myeloid leukemia (AML) therapeutics! 🔬 https://t.co/Hz4…

Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia. https://t.co/4rb1FFg6dy

Pubmed: Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia https://t.co/vix5qIi9OE

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.